Daptomycin Injection, Powder, Lyophilized, For Solution
Product Images NDC 71839-107

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Daptomycin (NDC 71839-107). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Be Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Daptocarton (Daptocarton)

Daptomycin for Injection 500 mg per vial powder label for lyophilized injection, for intravenous infusion. The label states the product must be refrigerated and reconstituted with 0.9% Sodium Chloride Injection. It is distributed by BE Pharmaceuticals Inc. and made in India. The NDC is 71839-107.*

FDA Label Image

Daptologo (Daptologo)

FDA Label Image

Daptostr (Daptostr)

Chemical structure of daptomycin, displaying its cyclic lipopeptide molecular composition with peptide bonds, side chains, and functional groups represented by standard organic chemistry notation.*

FDA Label Image

Daptoviallabel

Label for daptomycin for injection, 500 mg per vial, lyophilized powder for intravenous infusion, by BE Pharmaceuticals Inc. The label states it must be refrigerated between 2°C to 8°C (36°F to 46°F) and reconstituted using 10 mL 0.9% sodium chloride injection. The product is single-dose, with discarded unused portions. Includes NDC 71839-107-01 and a barcode.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.